{"id":"W2077372959","doi":"10.1016/j.pharmthera.2009.11.001","title":"Glycaemic control in type 2 diabetes: Targets and new therapies","year":2009,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":192,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; National Institute for Health and Care Research","keywords":"Incretin; Medicine; Type 2 Diabetes Mellitus; Type 2 diabetes; Intensive care medicine; Diabetes mellitus; Disease; Bioinformatics; Pharmacology; Internal medicine; Endocrinology","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001817115,0.000518411,0.001823497,0.0003131533,0.00003867971,0.00002105359,0.0001595017,0.0002951922,0.0002283014],"category_scores_gemma":[0.000002433095,0.0003925052,0.0002041887,0.0002811836,0.00009653647,0.00004946348,0.00004167117,0.0004484078,0.00008218451],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001591354,"about_ca_system_score_gemma":0.0002194918,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000003375249,"about_ca_topic_score_gemma":0.000002433938,"domain_scores_codex":[0.9982971,0.0001744774,0.0004462959,0.0004238369,0.0001321476,0.0005261334],"domain_scores_gemma":[0.9992102,0.00019674,0.0001851824,0.0002223404,0.00003481684,0.0001507555],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00007099131,0.0002621592,0.0002836114,0.001555561,0.003453315,0.00005325493,0.0001024181,2.234654e-7,0.0000377432,0.00002236951,0.003778432,0.9903799],"study_design_scores_gemma":[0.003457671,0.0006075741,0.0001041138,0.001086825,0.01312845,0.000006373435,0.000006267952,0.00002548759,0.000008288909,0.0001226193,0.9811622,0.0002841562],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002065241,0.99537,0.000005081919,0.001363602,0.0005629737,0.001816268,0.000006783491,0.00008305932,0.0005856859],"genre_scores_gemma":[0.0003130347,0.9836537,0.0001209242,0.01402046,0.0003269949,0.00008370724,0.0000694895,0.00006491642,0.001346834],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9900958,"threshold_uncertainty_score":0.9998527,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06878506968200675,"score_gpt":0.3732650511662632,"score_spread":0.3044799814842565,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}